Sign in

You're signed outSign in or to get full access.

Laser Photonics (LASE)

--

Research analysts covering Laser Photonics.

Recent press releases and 8-K filings for LASE.

Laser Photonics Regains Nasdaq Compliance
LASE
Delisting/Listing Issues
  • Laser Photonics Corporation (LASE) has regained compliance with Nasdaq Listing Rule 5250(c)(1).
  • The company satisfied the periodic reporting requirement by filing its Form 10-Q for the quarter ended September 30, 2025, on December 23, 2025.
  • As a result, Nasdaq has closed the related compliance matter.
Dec 31, 2025, 2:00 PM
Laser Photonics Announces $4 Million Private Placement
LASE
  • Laser Photonics Corporation announced a $4 million private placement priced at-the-market under Nasdaq rules.
  • The offering includes the issuance and sale of 1,098,902 shares of common stock at a purchase price of $3.64 per share.
  • The placement also includes Series A warrants and Series B warrants, each to purchase up to 1,098,902 shares of common stock at an exercise price of $3.40 per share.
  • The Series A warrants will expire five years after issuance, while the Series B warrants will expire eighteen months after issuance.
  • The offering is expected to close on or about September 26, 2025.
Sep 26, 2025, 9:25 PM
Laser Photonics Corporation Issues Unsecured Promissory Notes and Plans PIPE Transaction
LASE
Debt Issuance
Convertible Preferred Issuance
  • Laser Photonics Corporation entered into a Note Purchase Agreement on September 12, 2025, issuing unsecured promissory notes with a total principal amount of $2,111,111.12.
  • The company received net proceeds of $1,129,400 from the notes, after accounting for a 10% Original Issuance Discount (OID), an 8% placement agency fee, a 1% non-accountable allowance, and the repayment of $509,600 owed to Hudson Global Ventures, LLC.
  • The notes are due within three months from September 12, 2025 (by December 12, 2025), or earlier upon a subsequent financing, and the proceeds will be used for general working capital.
  • Laser Photonics Corporation is required to consummate a PIPE transaction for the issuance of common stock or equivalents between October 5, 2025, and October 17, 2025, with RBW Capital Partners, LLC serving as the exclusive placement agent.
  • Noteholders have the opportunity to purchase up to 10% of any new equity or convertible securities issued by the company on a pro rata basis until the notes are repaid or for 18 months after closing, excluding certain exempted securities.
Sep 18, 2025, 9:00 PM
Laser Photonics Announces Warrant Exchange
LASE
  • Laser Photonics Corporation (LASE) announced on September 2, 2025, that it entered into definitive agreements to exchange certain outstanding warrants.
  • These warrants, issued in the August 2024 PIPE financing, had an exercise price of $4.34 per share and entitled holders to purchase up to an aggregate of 0.8 million shares of common stock.
  • In exchange for relinquishing these warrants, the warrant holders will receive an aggregate of 3.2 million shares of the Company's common stock.
  • CEO Wayne Tupuola stated that this transaction strengthens the company's ability to execute strategic growth initiatives, simplifies the capital structure, and removes the overhang of warrants with a full ratchet anti-dilution provision.
Sep 3, 2025, 9:21 PM
Laser Photonics Corporation Enters into Secured Convertible Note Financing
LASE
Debt Issuance
  • Laser Photonics Corporation closed a secured convertible note financing with Hudson Global Ventures, LLC on August 28, 2025.
  • The financing involves a $455,000 secured convertible promissory note, issued for an actual purchase price of $410,000, bearing 12% annual interest, and maturing in 12 months.
  • The note is convertible into common stock at a fixed price of $4.34 per share, subject to adjustments.
  • Additionally, the company issued 418,000 shares of common stock as commitment shares and a warrant for 157,258 shares of common stock, exercisable at $4.34 per share for five years.
  • The company acknowledged the potentially dilutive effect of the conversion and exercise shares on its common stock.
Sep 3, 2025, 9:15 PM